Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Eden vs ShedRx

Two GLP-1 providers, one scoreboard. We put Eden and ShedRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 2 · Grade A−

Eden

Visit Eden Full brief →

FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.

vs
No. 5 · Grade B+

ShedRx

Visit ShedRx Full brief →

The verdict

Eden takes this head-to-head.

Eden scores 91 to 87 on our six-factor Brief Score — Eden now advertises compounded semaglutide and tirzepatide at recurring monthly prices without a separate membership fee; its FDA warning history remains relevant.

That doesn't make ShedRx a bad call — it's best for people comparing several treatment formats who can confirm the selected program’s minimum term, billing cycle and total charge. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
89
86
Supply Reliability
92
86
Transparency
93
84
Access Breadth
90
85
Clinical Oversight
92
85
Track Record
89
86
EdenBrief Score 91 · 87ShedRx

Price, coverage & the tracker

EdenShedRx
Brief Score91/100 (A−)87/100 (B+)
Semaglutide$99/month for compounded semaglutide on the current GLP-1 program; no separate membership fee or long-term contract advertised$199/mo on the 1-month plan · $179/mo on 6 months · $159/mo only on a 12-month commitment (all plans carry a 2-month minimum); compounded injection
Tirzepatide$129/month for compounded tirzepatide on the current GLP-1 program; no separate membership fee or long-term contract advertised$299/mo on the 1-month plan · $269/mo on 6 months · $239/mo only on a 12-month commitment (all plans carry a 2-month minimum); compounded injection
CoverageAll 50 statesNot disclosed
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
On the trackerFallingprice fallingFallingprice falling

Eden: Current GLP-1 pages show $99/$129 each month, replacing the former separate-membership structure; confirm your selected program.

ShedRx: Its lowest tirzepatide rate is $239, and that needs the 12-month commitment; the one-month rung is $299.

● Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.